Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients

Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients

Aim. The aim of the study was to assess the association of genetic polymorphisms of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) with atrial fibrillation development in elderly patients with coronary artery disease (CAD), undergoing coronary artery b...

Full description

Bibliographic Details
Main Authors:	A. O. Rubanenko, O. A. Rubanenko, L. V. Limareva, Iu. V. Shchukin
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2018-11-01
Series:	Российский кардиологический журнал
Subjects:	elderly patients atrial fibrillation coronary artery bypass graft genetic polymorphisms matrix metalloproteinase-9 tissue inhibitor of matrix metalloproteinase-1
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2921

Similar Items

Matrix metalloproteinase-9 as an independent predictor of recurrence after catheter ablation of atrial fibrillation
by: A. V. Goryachiy, et al.
Published: (2017-05-01)

Matrix metalloproteinase-9 as an independent predictor of recurrence after catheter ablation of atrial fibrillation
by: A. V. Goryachiy, et al.
Published: (2017-05-01)

The serum matrix metalloproteinase-9 level is an independent predictor of recurrence after ablation of persistent atrial fibrillation
by: Gang Wu, et al.
Published: (2016-05-01)

Matrix Metalloproteinases in Cardioembolic Stroke: From Background to Complications
by: Anna Wysocka, et al.
Published: (2023-02-01)

Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients
by: Ivanišević Jasmina, et al.
Published: (2017-01-01)

Oral direct renin inhibitor aliskiren reduces in vivo oxidative stress and serum matrix metalloproteinase-2 levels in patients with permanent atrial fibrillation
by: Yoshizumi Takei, MD, et al.
Published: (2015-04-01)

Tissue inhibitor of matrix metalloproteinase-1 role in left atrium matrix remodeling in patients with atrial febrillation
by: A. V. Goryachiy, et al.
Published: (2017-04-01)

Tissue inhibitor of matrix metalloproteinase-1 role in left atrium matrix remodeling in patients with atrial febrillation
by: A. V. Goryachiy, et al.
Published: (2017-04-01)

The content of matrix metalloproteinase-1, -9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity
by: V. V. Kachkovska, et al.
Published: (2023-12-01)

Expression of matrix metalloproteinase-2 and 9 with their inhibitors, tissue inhibitors of metalloproteinase-1 and 2 in oral lichen planus
by: Natheer Hashim Al-Rawi, et al.
Published: (2014-01-01)

Comparative characteristic of methods for determining the inflammation marker matrix metalloproteinase-9
by: E. V. Baranova, et al.
Published: (2014-12-01)

Expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in recurrent chronic rhinosinusitis with nasal polyposis
by: Ling-Feng Wang, et al.
Published: (2013-01-01)

Polymerizable Matrix Metalloproteinases’ Inhibitors with Potential Application for Dental Restorations
by: Helena Laronha, et al.
Published: (2021-03-01)

MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES DURING PREGNANCY AND DELIVERY
by: Yu. V. Korenovsky, et al.
Published: (2012-09-01)

Pathophysiological Role of Chymase-Activated Matrix Metalloproteinase-9
by: Shinji Takai, et al.
Published: (2022-10-01)

Asthma remodeling: The pathogenic role of matrix metalloproteinase-9
by: Amgad A. Farhat, et al.
Published: (2014-10-01)

Immunohistochemical expression of matrix metalloproteinase -9 in invasive meningioma
by: Samar U. Hasan*, et al.
Published: (2021-07-01)

Comparative analysis of content of the matrix metalloproteinase-9 in patients with acute cerebral strokes of different types
by: E. V. Baranova
Published: (2014-10-01)

Quercetin prevent proteoglycan destruction by inhibits matrix metalloproteinase-9, matrix metalloproteinase-13, a disintegrin and metalloproteinase with thrombospondin motifs-5 expressions on osteoarthritis model rats
by: Dian Agustina Permatasari, et al.
Published: (2019-01-01)

Molecular interactions of tannic acid and matrix metalloproteinases 2 and 9
by: Ya-Tang Chiang, et al.
Published: (2023-01-01)

The relationship between the first episode of wheezing and matrix metalloproteinases-9 and MMP-2 and tissue inhibitors of MMP-1 levels in preterm infants
by: Rabia Gonul Sezer, et al.
Published: (2013-01-01)

The Role of Matrix Metalloproteinases in Colorectal Cancer
by: Anan H. Said, et al.
Published: (2014-02-01)

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
by: Griselda A Cabral-Pacheco, et al.
Published: (2020-12-01)

Evaluation of matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in bronchoalveolar lavage of apparently healthy smokers
by: Ali M. Abdella, et al.
Published: (2015-04-01)

Plasma matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 as prognostic biomarkers in critically ill patients
by: Duda Izabela, et al.
Published: (2020-03-01)

Matrix metalloproteinase-9, its inhibitor-1 and interleukines in experimental traumatic brain injury
by: S. V. Ziablitsev, et al.
Published: (2016-12-01)

Perioceutics: Matrix metalloproteinase inhibitors as an adjunctive therapy for inflammatory periodontal disease
by: Esther Nalini Honibald, et al.
Published: (2012-01-01)

Matrix Metalloproteinases in Health and Disease
by: Raffaele Serra
Published: (2020-08-01)

Assessment of the Relationship Between Matrix Metalloproteinase-9 Promoter Gene Polymorphism and Chronic Periodontitis
by: Hiroj Bagde, et al.
Published: (2021-11-01)

Eotaxin-induced expression of membrane type 1 matrix metalloproteinase mRNA in human eosinophils
by: Izumi Kurosaki, et al.
Published: (2000-01-01)

ELISA study of matrix metalloproteinases 2, 7, 9 and their type 2 tissue inhibitor in the tumors of gastric cancer patients: clinical and pathologic correlations
by: E. S. Gershtein, et al.
Published: (2018-09-01)

Identification of matrix metalloproteinase-2 and -9 activities within the intestinal mucosa of dogs with chronic enteropathies
by: Mohsen Hanifeh, et al.
Published: (2018-03-01)

Matrix Metalloproteinases and Heart Transplantation—A Pathophysiological and Clinical View
by: Gabriela Patrichi, et al.
Published: (2023-07-01)

Galectin-3 and matrix metalloproteinases 2 and 9 in peripheral blood of gastric cancer patients
by: Ekaterina A. Korotkova, et al.
Published: (2023-05-01)

Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances
by: Hao Huang
Published: (2018-09-01)

Structure and Function of Human Matrix Metalloproteinases
by: Helena Laronha, et al.
Published: (2020-04-01)

Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases Ratio: A Biomarker of Bone Resorption in Geriatric Osteoporosis?
by: Bahar Bektan Kanat, et al.
Published: (2023-06-01)

Matrix metalloproteinases, inhibitor of metalloproteinases mRNA and protein expression in laryngeal squamous cell carcinoma
by: Weronika Lucas Grzelczyk, et al.
Published: (2019-04-01)

Role of Matrix Metalloproteinases in Musculoskeletal Diseases
by: Lokender Kumar, et al.
Published: (2022-10-01)

Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis
by: Krzysztof Szymanowski, et al.
Published: (2016-09-01)